Minnesota follows closely, seeing a 30.6 percent increase in obesity over 10 years. The state’s current obesity rate is 33.3 ...

After a period of diversification, Novo Nordisk is returning to its roots by focusing on the 2 billion people with diabetes, ...

Novo Nordisk A/S is back on the hunt for deals to boost its obesity portfolio after losing US biotech Metsera Inc. in a ...

The Obesity Association, a division of the American Diabetes Association (ADA), has issued new standards of care on the ...

Oral weight-loss drugs could account for a third or more of the overall GLP-1 market by 2030, a Novo Nordisk executive said ...

Obesity took center stage on the first day of the 2026 J.P. Morgan Healthcare Conference, with industry frontrunners Eli ...

Amgen's research chief said the company is very confident about its experimental obesity drug MariTide, as it prepares on ...

Metabolic and bariatric surgery are associated with a reduced risk for adverse kidney outcomes in patients with obesity, ...

Learn how GLP-1 medications support weight loss and heart health in perimenopause and postmenopause, plus get tips for ...

CenterWell Pharmacy announced that it will dispense Eli Lilly's obesity drugs within employer weight management programs. | ...

New research calls for routine risk stratification of MASLD in people with obesity to detect and manage liver disease earlier ...

The Nevada Independent is a nonpartisan, nonprofit news and opinion website founded in 2017 by veteran political journalist ...